The current landscape of preclinical drug development is plagued by slow progress, soaring costs, and a frustratingly high rate of failure. At CellCipher, we believe we can break this cycle and create a more effective path for drug development by improving the predictive power of preclinical toxicity testing and by enabling precision medicine for clinical trials.
Company Details
- Employees
- 2
- Founded
- -
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.cellcipher.org
Cellcipher Questions
Cellcipher's website is http://www.cellcipher.org
Cellcipher's LinkedIn profile is https://www.linkedin.com/company/cellcipher
Cellcipher has
2 employees.
View email and phone details for 2
employees at Cellcipher.
Cellcipher's industry is
Biotechnology Research
Cellcipher's top competitors are
Biomesense,
Anastasis Biotec,
Inomagen Therapeutics,
Ellis Bio,
Chicago Biomedical Consortium,
Claudyn Biotech,
Synthbits,
Clostrabio, Inc,
Reax Biotechnologies,
Orisdx.
Cellcipher's categories are Biotechnology Research
Cellcipher's founding year is 2023
